NextCure and Simcere Zaiming Announce Strategic Partnership for a Novel Antibody-Drug Conjugate Targeting CDH6
Globenewswire· 2025-06-16 11:05
NextCure gains global rights to SIM0505 excluding greater China, where Simcere Zaiming will retain rightsPhase 1 clinical trial ongoing for SIM0505 in China; U.S. Phase 1 clinical trial is expected to begin in the third quarter of 2025Initial Phase 1 clinical data is expected in the first half of 2026NextCure also gains rights to Simcere Zaiming’s proprietary linker and payload for use in an ADC directed to a NextCure novel target; Simcere Zaiming will have rights to greater China BELTSVILLE, Md. and SHANGH ...
RYVYL Appoints Industry Veteran Brett Moyer to Its Board of Directors
Globenewswire· 2025-06-16 11:05
SAN DIEGO, CA, June 16, 2025 (GLOBE NEWSWIRE) -- RYVYL Inc. (NASDAQ: RVYL) ("RYVYL” or the "Company"), a leading innovator of payment transaction solutions leveraging electronic payment technology, has appointed industry veteran Brett Moyer as an independent member of its board of directors, effective immediately. “I’m delighted to welcome Brett Moyer to our board,” said RYVYL Co-founder and Chairman Ben Errez. “Brett’s experience in building companies and proven expertise in scaling and licensing technolog ...
Ocugen, Inc. Announces U.S. FDA Clearance of Investigational New Drug Amendment to Initiate Phase 2/3 Pivotal Confirmatory Clinical Trial of OCU410ST—Modifier Gene Therapy Candidate for Stargardt Disease
Globenewswire· 2025-06-16 11:02
MALVERN, Pa., June 16, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) amendment to initiate a Phase 2/3 pivotal confirmatory trial of OCU410ST, a modifier gene therapy candidate being developed for all Stargardt disease (ABCA4-associated retinopathies). The FDA previously granted Rare Pediatr ...
Mark Ford Joins Highway as Chief Capacity Officer
GlobeNewswire News Room· 2025-06-16 11:01
DALLAS, June 16, 2025 (GLOBE NEWSWIRE) -- Highway announced today that Mark Ford will join the company as Chief Capacity Officer, a strategic addition to the executive team as the company accelerates growth and advances its long-term vision to redefine trust and identity in freight. Ford brings more than 30 years of experience leading carrier strategy, operations, and network development at some of the industry’s most recognized third-party logistics providers. Most recently, he served as Chief Capacity Off ...
VivoPower Advances US$308 Million Direct NASDAQ Spin-Off of Caret Digital
Prnewswire· 2025-06-16 11:00
Caret Digital subsidiary is to be spun off via a direct NASDAQ IPO at a target market capitalisation of US$308 millionNegotiations are progressing with strategic pre-IPO investors in the Middle East and Asia for investment of up to US$50 millionDedicated management team identified as well as renewable power sources at sub 3c/wattVivoPower shareholders as of future record date to receive five Caret Digital shares per VVPR share heldCaret Digital to continue mining DOGE following successful first phase, with ...
USA Rare Earth and Moog Sign Memorandum of Understanding for Delivery of U.S.-Made Neo Magnets for Data Center Cooling Solutions
Globenewswire· 2025-06-16 11:00
USAR to Qualify its Magnets for use in Moog’s CoreMotion™ Liquid Coolant Distribution PumpsSTILLWATER, Okla., June 16, 2025 (GLOBE NEWSWIRE) -- USA Rare Earth, Inc. (Nasdaq: USAR) (USAR or the Company) today announced it has signed a memorandum of understanding (MOU) with Moog Electric Motion Solutions (Moog) for delivery of the Company’s neo magnets, of which USAR plans to begin production in early 2026. Moog Electric Motion Solutions provides precision motion and fluid control systems and will begin proto ...
EverDriven Expands AI Video Safety Partnership with Powerfleet to Enhance Student Transportation Across 34 States
Prnewswire· 2025-06-16 10:59
WOODCLIFF LAKE, N.J., June 16, 2025 /PRNewswire/ -- Powerfleet (Nasdaq: AIOT), a global leader in AI-powered data intelligence, today announced an expanded deployment of its advanced AI video safety solution with EverDriven Technologies, a trusted leader in alternative student transportation across the United States.EverDriven operates across 34 states with 9,000+ drivers completing over 2 million trips annually. Due to the overwhelming interest from their school district partners,EverDriven will complete a ...
New Strong Sell Stocks for June 16th
ZACKS· 2025-06-16 10:50
Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:ADT Inc. (ADT) is a smart home solutions providing company. The Zacks Consensus Estimate for its current year earnings has been revised 1.2% downward over the last 60 days.DoubleDown Interactive Co., Ltd. (DDI) is a digital gaming company. The Zacks Consensus Estimate for its current year earnings has been revised 6.3% downward over the last 60 days.M/I Homes, Inc. (MHO) is a residential home-builder. The Zacks Consensus Estimate for ...
Pharvaris Presents Data Highlighting the Potential for Deucrictibant to Prevent and Treat Bradykinin-Mediated Angioedema Attacks at the EAACI Congress
Globenewswire· 2025-06-16 10:50
ZUG, Switzerland, June 16, 2025 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living with bradykinin-mediated diseases such as hereditary angioedema (HAE) and acquired angioedema due to C1 inhibitor deficiency (AAE-C1INH), today announced a summary of data that were presented at the European Academy of Allergy and Clinical Immunology (EAACI) Congress 2025. “Pharvaris embraced ...
VEON Announces USD 35 Million Share Buyback
Globenewswire· 2025-06-16 10:46
Announcement marks the third phase of USD 100 million share buyback program Dubai, June 16, 2025: VEON Ltd. (Nasdaq: VEON), a global digital operator (“VEON” or the “Company”), announces that it will shortly commence the third phase of its previously announced share buyback program with respect to the Company’s American Depositary Shares (“ADSs”). This third phase of the buyback will be in the amount of up to USD 35 million. The third phase of the share buyback program is being launched after the successf ...